Inhibition of the Fission Machinery Mitigates OPA1 Impairment in Adult Skeletal Muscles
Open accessAbstract
The maintenance of muscle mass and its ability to function relies on a bioenergetic efficient mitochondrial network. This network is highly impacted by fusion and fission events. We have recently shown that the acute deletion of the fusion protein Opa1 induces muscle atrophy, systemic inflammatory response, precocious epithelial senescence, and premature death that are caused by muscle-dependent secretion of FGF21. However, both fusion and fission machinery are suppressed in aging sarcopenia, cancer cachexia, and chemotherapy-induced muscle wasting. We generated inducible muscle-specific Opa1 and Drp1 double-knockout mice to address the physiological relevance of the concomitant impairment of fusion and fission machinery in skeletal muscle. Here we show that acute ablation of Opa1 and Drp1 in adult muscle causes the accumulation of abnormal and dysfunctional mitochondria, as well as the inhibition of autophagy and mitophagy pathways. This ultimately results in ER stress, muscle loss, and the reduction of force generation. However, the simultaneous inhibition of the fission protein Drp1 when Opa1 is absent alleviates FGF21 induction, oxidative stress, denervation, and inflammation rescuing the lethal phenotype of Opa1 knockout mice, despite the presence of any muscle weakness. Thus, the simultaneous inhibition of fusion and fission processes mitigates the detrimental effects of unbalanced mitochondrial fusion and prevents the secretion of pro-senescence factors.
AI snapshot
Written from the paper’s full text.
TL;DR
Muscle-specific simultaneous deletion of Opa1 and Drp1 in adult mice causes abnormal mitochondria, impaired autophagy/mitophagy, ER stress, muscle atrophy, and weakness, but also mitigates the lethal systemic phenotype of Opa1 loss. Inhibiting fission when fusion is absent rescues FGF21 induction, oxidative stress, denervation, inflammation, and mortality, despite persistent muscle weakness.
Key findings
- Inducible muscle-specific Opa1/Drp1 double knockout (DKO) caused progressive atrophy: gastrocnemius fiber cross-sectional area was reduced by 35%, 50%, 60%, and 45% at 70, 90, 120, and 150 days, respectively, versus controls; muscle loss then stabilized from 150 to 365 days. DKO mice also lost white adipose tissue and showed reduced absolute and mass-normalized force.
- Mitochondria were abnormal and dysfunctional: EM showed 65% control-like mitochondria, 25% larger elongated mitochondria, and 10% with disrupted cristae or onion-like inner membrane structures; SDH staining showed larger puncta and central mitochondria-depleted areas. DKO fibers depolarized after oligomycin, with greater depolarization at 150 days than 70 days, and respiratory chain complexes I and IV were reduced while complex V slightly increased.
- Catabolic and quality-control pathways were altered: FoxO3 and E3 ligases Atrogin1, MuRF1, SMART, and MUSA1 were induced at 70 days; autophagic flux was impaired by colchicine assay (reduced LC3 II accumulation), mitophagy was blocked by mt-mKeima, and ER stress/UPR genes ATF4, GADD34, CHOP, and GADD45 were upregulated.
- Blocking fission in Opa1-null muscle rescued lethality: muscle and blood FGF21 peaked at 70 days and returned to control values by 365 days; GDF15 was high at 70 and 150 days but near control after one year; NCAM denervation marker appeared in 8% of fibers at 120 days and reverted by 365 days; oxidative stress was prevented, inflammation largely blunted, and the DKO survival curve was superimposed with controls.
Methods
- Generated tamoxifen-inducible muscle-specific Opa1/Drp1 DKO mice by crossing Drp1-floxed mice with HSA-Cre-ER Opa1 transgenic mice; tamoxifen chow was given ad libitum for 5 weeks, and muscles were collected at time points from 70 to 365 days. Controls were Cre-negative littermates also receiving tamoxifen. A constitutive MLC1f-Cre Opa1/Drp1 model was attempted but yielded no homozygous DKO mice, suggesting embryonic lethality.
- Used qPCR, immunoblotting, H&E and SDH histology, immunofluorescence, transmission EM, TMRM membrane potential measurement, mt-mKeima mitophagy assay, in vivo gastrocnemius force measurement, colchicine autophagic flux assay, OxyBlot protein carbonyl detection, blood glucose, and plasma FGF21 ELISA.
- Statistics: means ± SEM; two-tailed Student’s t-test or two-way ANOVA with Bonferroni multiple comparison test when ANOVA was significant; significance threshold p < 0.05.
Limitations
- The paper has no formal limitations section. It states that constitutive muscle-specific Opa1/Drp1 DKO mice were not viable and no homozygous mice were obtained, suggesting embryonic lethality and hindering further analysis.
- Evident from the text: the study is limited to mouse models with acute tamoxifen-inducible deletion, and several mechanistic conclusions rely on transcriptional/protein correlates and pathway activation rather than direct causal rescue experiments in vivo. Human relevance is inferred from prior observations of concomitant Opa1 and Drp1 decline in aging, cachexia, and myasthenia gravis, not directly tested here.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 56 cited sources checked · 0 supported · 0 flagged
- Findingown data
The reduction of body weight in DKO mice is secondary to a significant decrease in muscle mass and white adipose tissue.
“The reduction of body weight is secondary to a significant decrease in muscle mass (Figure 1C) and white adipose tissue (WAT) (Figure 1D).”
Quote in the paperNot a substantial claim - Findingown data
Acute ablation of Opa1 and Drp1 in adult muscle causes the accumulation of abnormal and dysfunctional mitochondria.
“Here we show that acute ablation of Opa1 and Drp1 in adult muscle causes the accumulation of abnormal and dysfunctional mitochondria, as well as the inhibition of autophagy and mitophagy pathways.”
Quote in the paperSubstantial claim - Findingown data
Muscle loss in DKO mice stabilized from 150 to 365 days after the deletion.
“Interestingly, muscle loss stabilized from 150 to 365 days after the deletion (Figure 1F).”
Quote in the paperNot a substantial claim - Findingown data
There was a progressive reduction of DKO gastrocnemius muscle mass.
“There was a progressive reduction of DKO gastrocnemius muscle mass (Figure 1E)”
Quote in the paperSubstantial claim - Findingown data
Acute ablation of Opa1 and Drp1 in adult muscle causes the inhibition of autophagy and mitophagy pathways.
“Here we show that acute ablation of Opa1 and Drp1 in adult muscle causes the accumulation of abnormal and dysfunctional mitochondria, as well as the inhibition of autophagy and mitophagy pathways.”
Quote in the paperSubstantial claim
- Findingown data
Muscle loss in DKO mice occurred not only in gastrocnemius muscles but also in soleus.
“Importantly, muscle loss occurred not only in gastrocnemius muscles but also in soleus, a muscle with different metabolic properties, and fiber type composition (slow oxidative fibers) (Figure S1E, Supplementary Materials).”
Quote in the paperNot a substantial claim - Findingown data
Cross-sectional areas of individual fibers in DKO mice were significantly reduced by 35%, 50%, 60%, and 45% at 70, 90, 120, and 150 days, respectively, compared to controls.
“the cross-sectional areas of individual fibers were significantly reduced by 35%, 50%, 60%, and 45% at 70, 90, 120, and 150 days, respectively, compared to that of controls (Figure 1F).”
Quote in the paperSubstantial claim - Findingown data
OPA1 and DRP1 transcripts and proteins were efficiently reduced at both 70 and 150 days in DKO mice.
“OPA1 and DRP1 transcripts (Figure 1A) and proteins (Figure 1B; Figure S1B, Supplementary Materials) were efficiently reduced at both 70 and 150 days.”
Quote in the paperSubstantial claim - Findingown data
Within 35 days from the beginning of tamoxifen treatment, both male and female DKO mice began losing body weight.
“Interestingly, within 35 days from the beginning of tamoxifen treatment, both male and female DKO mice began losing body weight (Figure S1C,D, Supplementary Materials).”
Quote in the paperNot a substantial claim - Findingown data
Force normalized for muscle mass was significantly decreased in DKO mice.
“Moreover, we observed a significant decrease in DKO mice when we analyzed the force normalized for muscle mass.”
Quote in the paperSubstantial claim - Findingown data
Maximal absolute force (tetanic force) of gastrocnemius muscles in living DKO mice at 70 days after tamoxifen treatment was significantly reduced.
“Maximal absolute force (tetanic force) was significantly reduced (Figure S1H, Supplementary Materials), suggesting an increased loss of sarcomeric proteins.”
Quote in the paperSubstantial claim - Findingown data
Simultaneous inhibition of the fission protein Drp1 when Opa1 is absent rescues the lethal phenotype of Opa1 knockout mice.
“However, the simultaneous inhibition of the fission protein Drp1 when Opa1 is absent alleviates FGF21 induction, oxidative stress, denervation, and inflammation rescuing the lethal phenotype of Opa1 knockout mice, despite the presence of any muscle weakness.”
Quote in the paperSubstantial claim - Findingown data
Confocal microscopy on 70 days DKO isolated fibers immunostained for VDAC reported the typical mitochondrial network striation as seen in controls.
“Confocal microscopy on 70 days DKO mice isolated fibers that were immunostained for the mitochondrial protein Voltage-Dependent Anion Channel (VDAC) reported the typical mitochondrial network striation as seen in controls (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
In DKO muscles, GDF15 levels were almost reduced to control levels after one year from OPA1/DRP1 deletion.
“However, after one year from the OP1/DRP1 deletion, GDF15 levels were almost reduced to control levels (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
In control muscles, colchicine treatment caused LC3 II accumulation, indicating that autophagy was ongoing.
“As expected, LC3 II accumulated in control muscles upon colchicine treatment, indicating that autophagy was ongoing in these muscles (Figure 3D,E).”
Quote in the paperSubstantial claim - Findingown data
In DKO colchicine-treated muscles, LC3 II accumulation was significantly reduced.
“In contrast, LC3 II accumulation was significantly reduced in DKO colchicine-treated muscles (Figure 3E).”
Quote in the paperSubstantial claim - Findingown data
Denervation markers Musk1, AchR gamma, Runx1, and myogenin peaked at 120 and 150 days and returned to control levels after 365 days from tamoxifen treatment in DKO mice.
“Additionally, several denervation markers like Musk1, AchR gamma, Runx1, and myogenin peaked at 120 days and 150 days, and returned to control levels after 365 days from tamoxifen treatment (Figure S3C, Supplementary Materials).”
Quote in the paperNot a substantial claim - Findingown data
DKO fibers contain longitudinal VDAC-positive elongated structures.
“However, we noticed the presence of longitudinal VDAC-positive elongated structures in DKO fibers (Figure 2A, indicated by white arrows).”
Quote in the paperNot a substantial claim - Findingown data
Sixty-five percent of observed mitochondria in 70 days DKO EDL were similar to controls with an electron-dense matrix, parallel internal cristae, and placed at I band in the proximity of Z lines.
“Sixty-five percent of the observed mitochondria were similar to the controls with an electron-dense matrix, parallel internal cristae and placed at I band in the proximity of Z lines (Figure 2B, insets b and c, indicated by white arrows).”
Quote in the paperSubstantial claim - Findingown data
At 150 days, the percentage of NCAM-positive fibers was similar in gastrocnemius and soleus muscles of DKO mice.
“Interestingly, at 150 d, the percentage of NCAM-positive fibers was similar in both gastrocnemius (Figure 4E) and soleus muscles (Figure S3B, Supplementary Materials).”
Quote in the paperNot a substantial claim - Findingown data
Several fibers in both 70 days and 150 days DKO muscles displayed central areas depleted of mitochondria.
“Interestingly, several fibers displayed central areas depleted of mitochondria (Figure 2C, indicated by white arrows) in both 70 days and 150 days DKO muscles.”
Quote in the paperNot a substantial claim - Findingown data
The survival curve of DKO mice was superimposed with control mice.
“Finally, the survival curve of DKO mice was superimposed with control mice (Figure 4H).”
Quote in the paperSubstantial claim - Findingown data
In DKO muscles, GDF15 levels dramatically increased at 70 and 150 days.
“GDF15 levels dramatically increased at 70 days and 150 days DKO muscles (Figure 4C).”
Quote in the paperNot a substantial claim - Findingown data
Ten percent of observed mitochondria in 70 days DKO EDL had disrupted cristae structures or onion-like inner membrane structures.
“and 10% were mitochondria with disrupted cristae structures (Figure 2B, inset e) or with onion-like inner membrane structures (Figure 2B, inset f).”
Quote in the paperNot a substantial claim - Findingown data
In DKO muscles, there were no differences in the phosphorylation levels of S6 S240/244 despite an increase in total S6.
“there were no differences in the phosphorylation levels of S6 S240/244 despite the increase in total S6”
Quote in the paperNot a substantial claim - Findingown data
Mitochondria from DKO FDB myofibers underwent significant depolarization when F1F0-ATPase was inhibited by oligomycin.
“Mitochondria from DKO FDB myofibers underwent a significant depolarization when F1F0-ATPase was inhibited by oligomycin, suggesting that these fibers were in part relying on the reverse activity of ATP synthase to preserve their membrane potential because of proton leak-consuming proton motive force, in line with the morphological abnormalities.”
Quote in the paperSubstantial claim - Findingown data
ATF4 target genes GADD34, CHOP, and GADD45 were upregulated in 70-day DKO muscles.
“All these genes were upregulated in 70 days DKO muscles”
Quote in the paperSubstantial claim - Findingown data
Combined genetic ablation of fusion and fission genes completely prevented oxidative stress in DKO muscles.
“The combined genetic ablation of fusion and fission genes completely prevented oxidative stress (Figure 4F; Figure S3F, Supplementary Materials)”
Quote in the paperSubstantial claim - Findingown data
FoxO3, Atrogin 1, and MuRF1 progressively decreased from 150 to 365 days in DKO muscles.
“FoxO3, Atrogin 1, and MuRF1 progressively decreased from 150 to 365 days (Figure S2B, Supplementary Materials).”
Quote in the paperNot a substantial claim - Findingown data
Mitochondria in 70 days DKO EDL muscles were heterogeneous in size and morphology.
“Mitochondria were heterogeneous in size and morphology.”
Quote in the paperNot a substantial claim - Findingown data
Mitochondrial depolarization was enhanced in 150 days DKO mice compared to 70 days DKO mice.
“Of note, mitochondrial depolarization was enhanced in 150 days DKO mice compared to in 70 days DKO mice (Figure 2D).”
Quote in the paperNot a substantial claim - Findingown data
FoxO3 and its downstream E3 ligases Atrogin 1, MuRF1, SMART and MUSA1 were induced in 70-day DKO muscles.
“FoxO3, as well as its downstream target genes, the E3 ligases, Atrogin 1, MuRF1, SMART and MUSA1, were induced in 70 days DKO muscles (Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
Mitophagy was blocked in DKO muscles.
“The measurements showed that mitophagy was blocked in DKO muscles (Figure 3F).”
Quote in the paperSubstantial claim - Findingown data
Combined genetic ablation of fusion and fission genes slightly increased only IL-6 expression in DKO muscles at 120 days.
“slightly increased only IL-6 expression in DKO muscles at 120 days (Figure 4G).”
Quote in the paperNot a substantial claim - Findingown data
FoxO-dependent autophagy-related genes were upregulated in DKO mice.
“we found an upregulation of most of these genes in DKO mice (Figure 3C).”
Quote in the paperNot a substantial claim - Findingown data
Twenty-five percent of observed mitochondria in 70 days DKO EDL were larger elongated mitochondria, longitudinally oriented between myofibrils.
“However, 25% of mitochondria were larger elongated mitochondria, longitudinally oriented between myofibrils (Figure 2B, insets b and d, indicated by asterisks)”
Quote in the paperSubstantial claim - Findingown data
No homozygous mice with the double deletion of OPA1 and DRP1 were identified in the genotype analysis of more than 100 pups from the Myosin Light Chain-Cre cross.
“analysis of the genotype of the expected Mendelian distribution of more than 100 pups identified no homozygous mice with the double deletion of OPA1 and DRP1”
Quote in the paperSubstantial claim - Findingnone given
Muscle loss increased progressively within 120 days from the start of tamoxifen treatment in DKO mice.
“It is important to note that muscle loss increased progressively within 120 days from the start of tamoxifen treatment.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Simultaneous inhibition of fusion and fission processes prevents the secretion of pro-senescence factors.
“Thus, the simultaneous inhibition of fusion and fission processes mitigates the detrimental effects of unbalanced mitochondrial fusion and prevents the secretion of pro-senescence factors.”
Quote in the paperSubstantial claim - Interpretationown data
Simultaneous inhibition of fusion and fission processes mitigates the detrimental effects of unbalanced mitochondrial fusion.
“Thus, the simultaneous inhibition of fusion and fission processes mitigates the detrimental effects of unbalanced mitochondrial fusion and prevents the secretion of pro-senescence factors.”
Quote in the paperSubstantial claim - Interpretationown data
Disruption of both mitochondrial fission and fusion in adult skeletal muscles leads to alterations in mitochondrial morphology, distribution, and function.
“Thus, the disruption of both mitochondrial fission and fusion in the adult skeletal muscles leads to alterations in mitochondrial morphology, distribution, and function.”
Quote in the paperSubstantial claim - Premisecitation
Drp1 inhibition in muscles causes muscle weakness and wasting that is consequent to an abnormal calcium homeostasis.
“In muscles, the Drp1 inhibition causes muscle weakness and wasting that is consequent to an abnormal calcium homeostasis [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Favaro, 2019, Drp1-mediated mitochondrial shape controls calcium homeostasis and muscle mass, Nat. Commun. source
Not checked in the free run.
- Premisecitation
Both fusion and fission machinery are suppressed in aging sarcopenia, cancer cachexia, and chemotherapy-induced muscle wasting.
“However, both fusion and fission machinery are suppressed in aging sarcopenia, cancer cachexia, and chemotherapy-induced muscle wasting.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [3] Romanello, 2015, Mitochondrial Quality Control and Muscle Mass Maintenance, Front. Physiol.
Not checked in the free run.
- cites [15] Barreto, 2016, Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways, Front. Physiol. source
Not checked in the free run.
- cites [16] Brown, 2017, Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice, J. Cachex- Sarcopenia Muscle source
Not checked in the free run.
- Premisecitation
Acute inhibition of Opa1 in skeletal muscles led to premature death of 8-month-old adult mice within 120 days from tamoxifen-induced deletion.
“Acute inhibition of Opa1 in skeletal muscles led to the premature death of 8-month-old adult mice within 120 days from the tamoxifen-induced deletion [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- Premisecitation
In humans, there are significant age-dependent decreases of the mitochondrial shaping proteins Mfn1, Mfn2, Opa1, and Drp1 that correlate with muscle wasting.
“We provided evidence that, in humans, there are significant age-dependent decreases of the mitochondrial shaping proteins, Mfn1, Mfn2, Opa1, and Drp1 that correlate with muscle wasting [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- Interpretationown data
The upregulation of ATF4 target genes indicates activation of a PERK-dependent unfolded protein response in 70-day DKO muscles.
“which indicated the activation of a PERK-dependent Unfolded Protein Response (UPR) (Figure 3G).”
Quote in the paperSubstantial claim - Interpretationown data
General autophagy flux is impaired in DKO muscles.
“These findings indicated an impairment of general autophagy flux.”
Quote in the paperSubstantial claim - Interpretationown data
The central areas depleted of mitochondria in DKO muscles resembled central core disease where regions of myofiber cytoplasm are completely devoid of mitochondria.
“This resembled a central core disease where regions of myofiber cytoplasm were completely devoid of mitochondria.”
Quote in the paperNot a substantial claim - Premisecitation
Sarcopenic muscles have alterations in both mitochondrial fusion and fission processes.
“However, sarcopenic muscles have alterations in both mitochondrial fusion and fission processes [3].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Romanello, 2015, Mitochondrial Quality Control and Muscle Mass Maintenance, Front. Physiol.
Not checked in the free run.
- Interpretationown data
Simultaneous reduction of Opa1 and Drp1 in skeletal muscle acts as a compensatory mechanism to alleviate the detrimental effects of unbalanced mitochondrial dynamics.
“Here, we identified that the simultaneous reduction of Opa1 and Drp1 in skeletal muscle acts as a compensatory mechanism to alleviate the detrimental effects of unbalanced mitochondrial dynamics (Table S4, Supplementary Materials).”
Quote in the paperSubstantial claim - Premisecitation
Deletion of both Opa1 and Fgf21 significantly reverts precocious aging and mortality.
“In fact, the deletion of both Opa1 and Fgf21 significantly reverts precocious aging and mortality [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- Interpretationown data
DKO FDB myofibers were in part relying on the reverse activity of ATP synthase to preserve their membrane potential because of proton leak-consuming proton motive force.
“Mitochondria from DKO FDB myofibers underwent a significant depolarization when F1F0-ATPase was inhibited by oligomycin, suggesting that these fibers were in part relying on the reverse activity of ATP synthase to preserve their membrane potential because of proton leak-consuming proton motive force, in line with the morphological abnormalities.”
Quote in the paperSubstantial claim - Premisecitation
Overexpression of the fission proteins Drp1 and Fis1 in muscles causes muscle atrophy.
“On the other hand, the overexpression of the fission proteins Drp1 and Fis1 in muscles causes muscle atrophy [5,7].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Romanello, 2010, Mitochondrial fission and remodelling contributes to muscle atrophy, EMBO J. source
Not checked in the free run.
- cites [7] Touvier, 2015, Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation, Cell Death Dis. source
Not checked in the free run.
- Premisecitation
Mild mitochondrial stress might elicit beneficial effects on health and lifespan through activation of mitochondrial hormesis.
“Interestingly, mild mitochondrial stress might elicit beneficial effects on health and lifespan through the activation of mitochondrial hormesis [28,36].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28] Conte, 2018, Human Aging and Longevity Are Characterized by High Levels of Mitokines, J. Gerontol. Ser. A: Boil. Sci. Med Sci. source
Not checked in the free run.
- cites [36] Durieux, 2011, The Cell Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity, Cell source
Not checked in the free run.
- Premisecitation
Muscle loss in aging sarcopenia, cancer cachexia, and myasthenia gravis is characterized by the decline of both fusion machinery and fission machinery.
“However, muscle loss in aging sarcopenia, cancer cachexia, and myasthenia gravis are characterized by the decline of both fusion machinery and fission machinery [6,11,12,15,16,17,18].”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- cites [11] Ibebunjo, 2013, Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia, Mol. Cell. Biol. source
Not checked in the free run.
- cites [12] Murgia, 2017, Single Muscle Fiber Proteomics Reveals Fiber-Type-Specific Features of Human Muscle Aging, Cell Rep. source
Not checked in the free run.
- cites [15] Barreto, 2016, Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways, Front. Physiol. source
Not checked in the free run.
- cites [16] Brown, 2017, Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice, J. Cachex- Sarcopenia Muscle source
Not checked in the free run.
- cites [17] Grefte, 2018, Mitochondrial dynamics in cancer-induced cachexia, Biochim. Biophys. Acta Rev. Cancer source
Not checked in the free run.
- cites [18] Song, 2018, Effect of Qiangji Jianli decoction on mitochondrial respiratory chain activity and expression of mitochondrial fusion and fission proteins in myasthenia gravis rats, Sci. Rep. source
Not checked in the free run.
- Interpretationreasoning
The initial increase of Fgf21 in 70-day DKO muscles and blood can explain the observed metabolic changes such as basal hypoglycemia and reduced epididymal pads.
“The initial increase of Fgf21 in 70 days DKO muscles and blood can explain the observed metabolic changes such as basal hypoglycemia and reduced epididymal pads.”
Quote in the paperNot a substantial claim - Interpretationown data
DKO is a genetic model that resembles a phenotype of aging sarcopenia.
“Overall, our results suggested that DKO is a genetic model that resembles a phenotype of aging sarcopenia (Table S5, Supplementary Materials).”
Quote in the paperSubstantial claim - Premisecitation
Failure in mitochondrial-shaping processes has detrimental consequences for the maintenance of muscle mass and function.
“Accordingly, the failure in mitochondrial-shaping processes has detrimental consequences for the maintenance of muscle mass and function [4,5,6,7,8,13,29].”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [4] Chen, 2010, Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations, Cell source
Not checked in the free run.
- cites [5] Romanello, 2010, Mitochondrial fission and remodelling contributes to muscle atrophy, EMBO J. source
Not checked in the free run.
- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- cites [7] Touvier, 2015, Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation, Cell Death Dis. source
Not checked in the free run.
- cites [8] Favaro, 2019, Drp1-mediated mitochondrial shape controls calcium homeostasis and muscle mass, Nat. Commun. source
Not checked in the free run.
- cites [13] Sorianello, 2016, Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway, EMBO J. source
Not checked in the free run.
- cites [29] Joseph, A.-M., Picca, A., Leeuwenburgh, C., Adhihetty, P.J., Wawrzyniak, N.R., Wohlgemuth, S.E., Kujoth, G.C., and Prolla, T.A. (2013). Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging. PLOS ONE, 8. source
Not checked in the free run.
- Interpretationown data
The dynamic control of mitochondrial shape by fusion and fission is important to maintain a healthy mitochondrial network during muscle development.
“This finding underscores the importance of the dynamic control of mitochondrial shape, by fusion and fission, to maintain a healthy mitochondrial network during muscle development.”
Quote in the paperSubstantial claim - Premisecitation
In humans, Fgf21 levels are inversely correlated with survival.
“Moreover, in humans, Fgf21 levels are inversely correlated with survival [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Conte, 2018, Human Aging and Longevity Are Characterized by High Levels of Mitokines, J. Gerontol. Ser. A: Boil. Sci. Med Sci. source
Not checked in the free run.
- Premisecitation
Similar changes in mitochondrial ultrastructure were observed in a recent study investigating acute downregulation of both Opa1 and Drp1 in Drosophila adult muscles.
“Similar changes were observed in a recent study that investigated the acute downregulation of both Opa1 and Drp1 in Drosophila adult muscles [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Trevisan, 2018, Manipulation of Mitochondria Dynamics Reveals Separate Roles for Form and Function in Mitochondria Distribution, Cell Rep. source
Not checked in the free run.
- Interpretationown data
Homozygous DKO mice died in utero.
“suggesting that homozygous DKO mice died in utero (Table S3, Supplementary Materials).”
Quote in the paperSubstantial claim
- May combine two claims. 51
- Classified as probably not a substantial claim. 9
May combine two claims.
Findingown dataExtending Opa1 and Drp1 ablation in muscles for 120, 150, and 365 days leads to myofiber death and the appearance of center-nucleated fibers in approximately 6%-8% of gastrocnemius fibers.
“However, extending Opa1 and Drp1 ablation in muscles for 120 days, 150 days, and 365 days leads to myofiber death and the appearance of center-nucleated fibers in approximately 6%–8% of gastrocnemius fibers (Figure 1G; Figure S1F, Supplementary Materials).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataH&E staining of transverse muscle sections at 70 days revealed very small fibers with no signs of inflammation, degeneration, or regeneration.
“Muscle histology analyses by H&E staining of transverse muscle sections revealed the presence of very small fibers with no signs of inflammation, degeneration, or regeneration at 70 days (Figure 1G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAcute ablation of Opa1 and Drp1 in adult muscle ultimately results in ER stress, muscle loss, and the reduction of force generation.
“This ultimately results in ER stress, muscle loss, and the reduction of force generation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMitochondria-rich oxidative fibers of soleus muscles display a more severe myopathic phenotype than gastrocnemius, with a dramatic increase of center-nucleated fibers (33%).
“Importantly, mitochondria-rich oxidative fibers of soleus muscles display a more severe myopathic phenotype, when compared to gastrocnemius, as revealed by the dramatic increase of center-nucleated fibers (33%) (Figure S1G, Supplementary Materials).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSimultaneous inhibition of the fission protein Drp1 when Opa1 is absent alleviates FGF21 induction, oxidative stress, denervation, and inflammation.
“However, the simultaneous inhibition of the fission protein Drp1 when Opa1 is absent alleviates FGF21 induction, oxidative stress, denervation, and inflammation rescuing the lethal phenotype of Opa1 knockout mice, despite the presence of any muscle weakness.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Findingnone givenSimultaneous inhibition of the fission protein Drp1 when Opa1 is absent does not prevent muscle weakness.
“However, the simultaneous inhibition of the fission protein Drp1 when Opa1 is absent alleviates FGF21 induction, oxidative stress, denervation, and inflammation rescuing the lethal phenotype of Opa1 knockout mice, despite the presence of any muscle weakness.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWestern blot analyses revealed a reduction of respiratory chain complexes I and IV and a slight increase of complex V in DKO mice compared to controls.
“Western blot analyses of the subunits of the different respiratory chain complexes revealed a reduction of complexes I and IV and a slight increase of complex V in DKO mice compared to that in controls (Figure 2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn DKO mice, Fgf21 levels in muscle and blood peaked at 70 days, then progressively reduced and reached control values at 365 days.
“The levels of Fgf21 in muscle (Figure 4A) and blood (Figure 4B) peaked in 70 days DKO but then were progressively reduced and then reached their control values at 365 days.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDKO mice had metabolic alterations at 70 days, including reduced WAT, liver steatosis, and low serum glucose levels.
“Like in Opa1-deleted mice, DKO mice had several metabolic alterations at 70 days such as reduced WAT (Figure 1D), liver steatosis (Figure S3D, Supplementary Materials) and low serum glucose levels (Figure S3E, Supplementary Materials).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSDH staining showed bigger puncta in muscle fibers, suggesting that mitochondria are larger in DKO mice than in control muscles.
“SDH staining showed bigger puncta in muscle fibers, suggesting that mitochondria are larger in DKO mice than in control muscles (Figure 2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNo homozygous MLC-Drp1/Opa1 Cre-positive-floxed mice were obtained, suggesting embryonic lethality.
“No homozygous MLC-Drp1/Opa1 Cre-positive-floxed mice were obtained, suggesting embryonic lethality (Table S3, Supplementary Materials).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 70-day DKO muscles, AKT phosphorylation was not affected, while total AKT increased.
“While AKT phosphorylation was not affected, the total AKT increased in 70 days DKO muscles.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe NCAM marker of denervation started to be expressed at 120 days in 8% of DKO fibers, but reverted to control values at 365 days.
“the NCAM marker of denervation started to be expressed at 120 days in 8% of DKO fibers, but then it reverted to the control values at 365 days (Figure 4D,E).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn DKO muscles, phospho-4EBP1 Thr37/46 and total 4EBP1 increased.
“Phospho-4EBP1 Thr37/46 and total 4EBP1 increased”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn DKO mice, WAT was partially recovered, liver steatosis ameliorated at 120 days, and glycemia restored to normal at 150 days after tamoxifen treatment.
“Consistent with the reduction of muscle and serum FGF21 in 150 days and 365 days DKO mice (Figure 4A,B), WAT was partially recovered (Figure 1D), liver steatosis ameliorated already at 120 days (Figure S3D), and glycemia was restored to normal levels at 150 days after tamoxifen treatment (Figure S3E, Supplementary Materials).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUltrastructural analysis by electron microscopy of 70 days DKO EDL muscles revealed a regular sarcomeric structure with the accumulation of lipid droplets.
“Ultrastructural analysis by electron microscopy of 70 days DKO EDL muscles revealed a regular sarcomeric structure with the accumulation of lipid droplets (Figure 2B, inset b, indicated by the black arrow).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAdult DKO mice showed evident kyphosis at 90 days, partially reverted at 150 and 365 days after deletion.
“Adult DKO mice showed an evident kyphosis at 90 days (Figure S3A, Supplementary Materials), which was partially reverted at 150 and 365 days after the deletion, keeping in line with FGF21 and GDF15 levels.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDKO muscles display muscle loss, autophagy/mitophagy flux impairment, a mixed population of both enlarged and normal mitochondria, and mild mitochondrial dysfunction in the absence of oxidative stress.
“Muscles display muscle loss, autophagy/mitophagy flux impairment, and a mixed population of both enlarged and normal mitochondria, as well as mild mitochondrial dysfunction in the absence of oxidative stress.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningAbolishment of mitochondrial dynamics in adult muscles resulted in muscle loss and weakness.
“The abolishment of mitochondrial dynamics in adult muscles resulted in muscle loss and weakness.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationFrom 150 to 365 days after deletion of Opa1 and Drp1, the transcriptional atrophy program was blunted, resulting in partial muscle mass recovery which correlates to reduced Fgf21 muscle levels, despite persistent mitochondrial dysfunction in DKO muscles.
“However, from 150 to 365 days after the deletion of Opa1 and Drp1, the transcriptional atrophy program was blunted, resulting in a partial muscle mass recovery which correlates to reduced Fgf21 muscle levels [23], despite persistent mitochondrial dysfunction in DKO muscles.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Oost, L.J., Kustermann, M., Armani, A., Blaauw, B., and Romanello, V. (2019). Fibroblast growth factor 21 controls mitophagy and muscle mass. J. Cachex- Sarcopenia Muscle. source
Not checked in the free run.
May combine two claims.
Findingown dataMuscle-specific DKO mice had a less severe phenotype than Opa1 knockout mice, which was dependent on muscle Gdf15 and Fgf21 levels.
“Here, we showed that muscle-specific DKO mice had a less severe phenotype than Opa1 knockout mice which were dependent on muscle Gdf15 and Fgf21 levels.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataElectron microscopy analyses revealed a heterogeneous mitochondrial population in DKO muscles: more than 65% resembled control mitochondria, 25% were abnormally enlarged, and 10% displayed abnormal inner organization.
“Electron microscopy analyses revealed the presence of a heterogeneous mitochondrial population in DKO muscles. More than 65% of the observed mitochondria resembled control mitochondria, 25% were abnormally enlarged, and 10% displayed abnormal inner organization.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningConsistent with reduced Fgf21 induction in 150-day DKO muscles, glycemia was normalized, and WAT was partially spared after 150 days compared to 120-day DKO muscles when muscle atrophy is maximal.
“Consistent to reduced Fgf21 induction in 150 days DKO muscles, glycemia was normalized, and WAT was partially spared after 150 days compared to that in 120 days DKO muscles when muscle atrophy is maximal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMuscle-specific ablation of both Mfn1 and Mfn2 induces muscle atrophy and abnormal muscle growth in mice.
“Muscle-specific ablation of both Mfn1 and Mfn2 induces muscle atrophy and abnormal muscle growth in mice [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Chen, 2010, Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationOpa1-null muscles released FGF21 to mediate an integrated stress response causing oxidative stress, systemic inflammation, metabolic alterations, precocious senescence, and premature death.
“We showed that Opa1-null muscles released FGF21 to mediate an integrated stress response which causes oxidative stress, systemic inflammation, metabolic alterations, precocious senescence of different epithelial tissues, and premature death [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
Interpretationown dataSimultaneous deletion of Opa1 and Drp1 prevented the precocious death of Opa1 knockout mice, counteracted oxidative stress, muscle and WAT loss, and prevented an inflammatory response.
“Thus, the simultaneous deletion of Opa1 and Drp1 prevented the precocious death of Opa1 knockout mice, counteracted oxidative stress, muscle and WAT loss, and prevented an inflammatory response.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataBesides a loss in mass, the skeletal muscles of DKO mice also had a lower intrinsic muscle force, revealing a myopathic phenotype.
“These results indicated that, besides a loss in mass, the skeletal muscles of DKO mice also had a lower intrinsic muscle force, revealing a myopathic phenotype (Figure 1H).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOverexpression of Opa1 protects from denervation-induced muscle loss and ameliorates muscle function in a mouse model of mitochondrial myopathy.
“Conversely, overexpression of Opa1 protects from denervation-induced muscle loss and ameliorates muscle function in a mouse model of mitochondrial myopathy [9,10].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Civiletto, 2015, Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models, Cell Metab. source
Not checked in the free run.
- cites [10] Varanita, 2015, The Opa1-Dependent Mitochondrial Cristae Remodeling Pathway Controls Atrophic, Apoptotic, and Ischemic Tissue Damage, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationThe concomitant decrease of Opa1 and Drp1 also occurs in cancer cachexia and chemotherapy-induced cachexia as well as a model of myasthenia gravis.
“Moreover, the concomitant decrease of Opa1 and Drp1 also occurs in cancer cachexia and chemotherapy-induced cachexia [15,16,17] as well as a model of myasthenia gravis [18].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [15] Barreto, 2016, Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways, Front. Physiol. source
Not checked in the free run.
- cites [16] Brown, 2017, Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice, J. Cachex- Sarcopenia Muscle source
Not checked in the free run.
- cites [17] Grefte, 2018, Mitochondrial dynamics in cancer-induced cachexia, Biochim. Biophys. Acta Rev. Cancer source
Not checked in the free run.
May combine two claims.
PremisecitationOpa1-null mice presented a phenotype of sarcopenia and premature unhealthy aging, recapitulating 24-30 months of life in a few weeks.
“Moreover, these mice presented a phenotype of sarcopenia and premature and unhealthy aging, in just a few weeks they recapitulated 24–30 months of life.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial dysfunction triggers expression in muscle of FGF21 and GDF15, which positively correlate with unhealthy aging and mortality.
“Since mitochondrial dysfunction triggers the expression in muscle of FGF21 and GDF15, which positively correlate with unhealthy aging and mortality [6,28], we measured the transcript levels of these hormones in DKO muscles.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
- cites [28] Conte, 2018, Human Aging and Longevity Are Characterized by High Levels of Mitokines, J. Gerontol. Ser. A: Boil. Sci. Med Sci. source
Not checked in the free run.
May combine two claims.
Interpretationown dataInhibition of mitochondrial fission in Opa1-null muscles mitigates FGF21 induction, denervation, oxidative stress, and inflammation, rescuing the lethal phenotype of Opa1 knockout mice.
“In conclusion, inhibition of mitochondrial fission in Opa1-null muscles mitigates FGF21 induction, denervation, oxidative stress, and inflammation, rescuing the lethal phenotype of Opa1 knockout mice.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMuscle-specific Opa1 knockout mice display fragmented mitochondria, muscle loss, and weakness which reverberates to the whole body and leads to premature aging and then mortality.
“Muscle-specific Opa1 knockout mice display fragmented mitochondria, muscle loss, and weakness which reverberates to the whole body and leads to premature aging and then mortality [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe signaling pathways causing muscle loss due to combined abrogation of mitochondrial fusion and fission involved activation of the UPS and impairment of general autophagy, mitophagy flux, and activation of UPR.
“In conclusion, the signaling pathways impinging on muscle loss due to the combined abrogation of mitochondrial fusion and fission involved the activation of the UPS and the impairment of general autophagy, as well as mitophagy flux and the activation of UPR.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMuscle-specific deletion of Opa1 triggered oxidative stress and upregulation of IL-6 and IL-1α in muscles.
“Muscle-specific deletion of Opa1 triggered oxidative stress and upregulation of Interleukin 6 (IL-6) and Interleukin 1-alpha (IL-1α) in muscles [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe AKT-mTOR pathway is not consistent and does not explain the observed muscle atrophy in DKO mice.
“Thus, the AKT-mTOR pathway is not consistent and does not explain the observed muscle atrophy.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataAll data were normalized to the reference gene GAPDH expression, of which abundance did not change under any of the experimental conditions.
“All data were normalized to the reference gene GAPDH expression, of which abundance did not change under any of the experimental conditions, and plotted in arbitrary units as mean ± SEM.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAcute deletion of the fusion protein Opa1 induces muscle atrophy, systemic inflammatory response, precocious epithelial senescence, and premature death caused by muscle-dependent secretion of FGF21.
“We have recently shown that the acute deletion of the fusion protein Opa1 induces muscle atrophy, systemic inflammatory response, precocious epithelial senescence, and premature death that are caused by muscle-dependent secretion of FGF21.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationSpecific deletion of Opa1 in muscle leads to oxidative stress, Endoplasmic Reticulum (ER) stress, and muscle atrophy.
“Moreover, the specific deletion of Opa1 in muscle leads to oxidative stress, Endoplasmic Reticulum (ER) stress, and muscle atrophy [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
Interpretationown dataBlocking mitochondrial dynamics in adult muscles causes WAT loss, progressive atrophy, and weakness.
“Thus, blocking mitochondrial dynamics in adult muscles causes WAT loss, progressive atrophy, and weakness.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataNo evidence of necrosis or inflammation was observed after the transfection procedure.
“No evidence of necrosis or inflammation was observed after the transfection procedure”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOpa1-null muscles reverberate systemically, inducing metabolic alterations, inflammation, precocious senescence of different epithelial tissues and premature death via Fgf21.
“Opa1-null muscles reverberate systemically, inducing metabolic alterations, inflammation, precocious senescence of different epithelial tissues and premature death via Fgf21 [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe resulting mitochondrial dysfunction leads to activation of ER stress, UPR, and FGF21 pathways which further contribute to muscle atrophy.
“Importantly, the resulting mitochondrial dysfunction leads to the activation of ER stress, UPR, and FGF21 pathways which further contribute to muscle atrophy.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationDespite a dramatic reduction in Fgf21 in 365-day DKO muscles, lipolysis might not be completely blocked because UCP1 is induced in WAT.
“Despite a dramatic reduction in Fgf21 in 365 days DKO muscles, lipolysis might not be completely blocked because UCP1 is induced in WAT [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationIn Opa1-deleted mice, chronic elevation of muscle-derived circulating Fgf21 mediated important metabolic changes, systemic inflammatory response, precocious senescence of epithelial tissues, and premature animal death.
“In Opa1-deleted mice, chronic elevation of muscle-derived circulating Fgf21 mediated important metabolic changes, systemic inflammatory response, precocious senescence of epithelial tissues, and premature animal death [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Tezze, 2017, Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence, Cell Metab. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationMitochondrial fusion and fission play crucial roles in the homeostatic control of muscle mass.
“Mitochondrial fusion and fission play crucial roles in the homeostatic control of muscle mass [3].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Romanello, 2015, Mitochondrial Quality Control and Muscle Mass Maintenance, Front. Physiol.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationcitationThe concomitant decline of mitochondrial dynamics in aging sarcopenia might be necessary to activate a mild mitochondrial dysfunction and thus mitohormesis, to promote healthy aging, while unhealthy/accelerated aging associates to unopposed mitochondrial fission.
“Thus, the concomitant decline of mitochondrial dynamics in aging sarcopenia might be necessary to activate a mild mitochondrial dysfunction and thus mitohormesis, to promote healthy aging while unhealthy/accelerated aging associates to unopposed mitochondrial fission.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe impossibility to maintain a healthy mitochondrial network by continuous reshaping of the organelle in DKO muscle leads to dysfunctional mitochondria which accumulate due to a block in mitophagy.
“The impossibility to maintain a healthy mitochondrial network by the continuous reshaping of the organelle in DKO muscle leads to dysfunctional mitochondria which accumulate due to a block in mitophagy.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSpecific abrogation of mitochondrial dynamics in the heart leads to less severe cardiomyopathy and reverts mortality compared to unopposed fission or fusion heart-specific mouse models.
“Like skeletal muscle, the specific abrogation of mitochondrial dynamics in the heart leads to less severe cardiomyopathy and reverts mortality in respect to unopposed fission or fusion heart-specific mice models [35].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Song, 2017, Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence, Cell Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther reports have associated high levels of circulating Fgf21 with the extension of lifespan.
“Conversely, other reports have associated high levels of circulating Fgf21 with the extension of lifespan [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Zhang, 2012, The starvation hormone, fibroblast growth factor-21, extends lifespan in mice, Abstract
Not checked in the free run.
May combine two claims.
Interpretationown dataA possible explanation for the observed ultrastructural mitochondrial alterations in DKO muscles is an unbalanced Mfn1-dependent outer mitochondrial membrane fusion, while fusion of the inner membrane together with mitochondrial fission is absent.
“A possible explanation for the observed ultrastructural mitochondria alterations is an unbalanced Mfn1-dependent outer mitochondrial membrane fusion in DKO muscles, while the fusion of the inner membrane together with mitochondrial fission is absent.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMuscle denervation, oxidative stress, and inflammation are mitigated in DKO muscles, rescuing the lethal phenotype of Opa1 knockout mice.
“Moreover, muscle denervation, oxidative stress, and inflammation are mitigated in DKO muscles, rescuing the lethal phenotype of Opa1 knockout mice.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationMuscle loss in DKO mice is due to FoxO-mediated activation of the ubiquitin-proteasome system together with impairment of general autophagy and mitophagy pathways.
“Mechanistically, muscle loss is due to FoxO-mediated activation of the ubiquitin–proteasome system together with the impairment of general autophagy and mitophagy pathways [25,31,32].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [25] Milan, 2015, Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy, Nat. Commun. source
Not checked in the free run.
- cites [31] Sandri, 2016, Protein breakdown in cancer cachexia, Semin. Cell Dev. Boil. source
Not checked in the free run.
- cites [32] Sartori, 2015, Bone and morphogenetic protein signalling and muscle mass, Curr. Opin. Clin. Nutr. Metab. Care source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOverexpression of either Atf4, Gadd45, or Fgf21 in muscles is sufficient to induce muscle atrophy.
“In fact, the overexpression of either Atf4 [27], Gadd45 [26], or Fgf21 [23] in muscles is sufficient to induce muscle atrophy.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [27] Ebert, 2010, The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting, J. Clin. Endocrinol. Metab. source
Not checked in the free run.
- cites [26] Ebert, 2012, Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy*, J. Boil. Chem. source
Not checked in the free run.
- cites [23] Oost, L.J., Kustermann, M., Armani, A., Blaauw, B., and Romanello, V. (2019). Fibroblast growth factor 21 controls mitophagy and muscle mass. J. Cachex- Sarcopenia Muscle. source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe discrepancy between inverse correlation of Fgf21 with survival and association with lifespan extension can most likely be explained by a threshold effect of Fgf21, where moderate levels result in adaptive responses to stress, while exacerbated levels are detrimental.
“The discrepancy in the two observations can most likely be explained by the threshold effect of Fgf21, where moderate levels result in adaptive responses to stress, while exacerbated levels are detrimental to stress [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Conte, 2018, Human Aging and Longevity Are Characterized by High Levels of Mitokines, J. Gerontol. Ser. A: Boil. Sci. Med Sci. source
Not checked in the free run.
The paper relies on this without support.
The physiological role of the combined inhibition of mitochondrial fusion and fission factors in muscles has not yet been fully investigated.
“However, the physiological role of the combined inhibition of mitochondrial fusion and fission factors in muscles has not yet been fully investigated.”
The paper relies on this without support.
Skeletal muscle fibers are postmitotic cells that do not divide and cannot dilute dysfunctional mitochondria through cellular division.
“Skeletal muscle fibers are postmitotic cells that do not divide, and as a consequence, they cannot dilute dysfunctional mitochondria through cellular division.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Impairment of fission leads to disruption of selective mitochondrial autophagic degradation, followed by dysfunctional organelle accumulation.
“Impairment of fission leads to the disruption of selective mitochondrial autophagic degradation, followed by dysfunctional organelles accumulation [58, 196–200].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
Acute muscle-specific ablation of OPA1 and DRP1 (DKO) shows a less severe phenotype when compared to OPA1 knockout mice.
“Acute muscle-specific ablation of OPA1 and DRP1 (DKO) [197] shows a less severe phenotype when compared to OPA1 knockout mice.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
FGF21 is dramatically increased in muscle and serum of all three models (OPA1, DRP1, DKO), though to different degrees.
“Interestingly, the stress-response myokine FGF21 is dramatically increased in muscle and serum of all these three models, even if with a different degree.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
There is strong evidence in skeletal muscle supporting a causal link between dysregulation of mitochondrial fission and alterations in muscle maintenance.
“There is strong evidence in skeletal muscle that supports a causal link between the dysregulation of mitochondrial fission and alterations in muscle maintenance [152, 196, 197, 210, 211].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
Simultaneous inhibition of OPA1 and DRP1 rescues mortality and FGF21 serum levels are only transiently elevated.
“Consistently, the simultaneous inhibition of OPA1 and DRP1 rescues mortality [197] and FGF21 serum levels are only transiently elevated.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
Muscle denervation, oxidative stress, and inflammation are mitigated in DKO muscles, rescuing the lethal phenotype of OPA1 knockout mice.
“Moreover, muscle denervation, oxidative stress, and inflammation are mitigated in DKO muscles, rescuing the lethal phenotype of OPA1 knockout mice [197].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
The atrophy program's initial activation and the induction of FGF21 resolve over time in DKO muscles despite persistent mitochondrial dysfunction.
“The atrophy program's initial activation and the induction of FGF21 resolve over time in DKO muscles despite persistent mitochondrial dysfunction.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
As a consequence of mitochondrial dysfunction, ER stress, UPR, and FGF21 pathways are activated and further contribute to muscle atrophy.
“As a consequence of mitochondrial dysfunction, ER stress, UPR, and FGF21 pathways are activated and further contribute to muscle atrophy.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
DKO mice show muscle loss and weakness due to FoxO-dependent activation of the ubiquitin-proteasome system and general autophagy impairment.
“DKO showed muscle loss and weakness due to FoxO-dependent activation of the ubiquitin–proteasome system and general autophagy impairment.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
Energy stress consequent to acute or chronic exercise triggers autophagy in different tissues.
“Energy stress consequent to acute or chronic exercise triggers autophagy in different tissues [197–200].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [197]
Deletion of OPA1 in the skeletal muscle of young mice alters mitochondrial morphology and function, leading to muscle loss and weakness.
“The deletion of OPA1 in the skeletal muscle of young mice also alters mitochondrial morphology and function, leading to muscle loss and weakness (85, 86).”
From From mitochondria to sarcopenia: role of 17β-estradiol and testosterone (2023) · cites this paper as [85]
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797 · see citing works
Self-citationMechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492 · see citing works
Self-citationCogliati, S., Frezza, C., Soriano, M. E., Varanita, T., Quintana-Cabrera, R., Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.032 · Cited by 1,265 · see citing works
Self-citationChen, H., Vermulst, M., Wang, Y. E., Chomyn, A., Prolla, T. A., McCaffery, J. M., & Chan, D. C. (2010) · Cell · doi:10.1016/j.cell.2010.02.026 · Cited by 1,211 · see citing works
The Cell Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity
Durieux, J., Wolff, S., & Dillin, A. (2011) · Cell · doi:10.1016/j.cell.2010.12.016 · Cited by 1,059 · see citing works
Human muscle metabolism during intermittent maximal exercise
Gaitanos, G. C., Williams, C., Boobis, L. H., & Brooks, S. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.2.712 · Cited by 967 · see citing works
Milan, G., Romanello, V., Pescatore, F., Armani, A., Paik, J.-H., Frasson, L., Seydel, A., Zhao, J., Abraham, R., Goldberg, A. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7670 · Cited by 709 · see citing works
Self-citationMitochondrial fission and remodelling contributes to muscle atrophy
Romanello, V., Guadagnin, E., Gomes, L., Roder, I., Sandri, C., Petersen, Y., Milan, G., Masiero, E., Del Piccolo, P., Foretz, M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.60 · Cited by 596 · see citing works
Self-citationTezze, C., Romanello, V., Desbats, M. A., Fadini, G. P., Albiero, M., Favaro, G., Ciciliot, S., Soriano, M. E., Morbidoni, V., Cerqua, C., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.021 · Cited by 568 · cited 23× · see citing works
“However, from 150 to 365 days after the deletion of Opa1 and Drp1, the transcriptional atrophy program was blunted, resulting in a partial muscle mass recovery which correlates to reduced Fgf21 muscle levels [23], despite persistent mitochondrial dysfunction in DKO muscles.”
InfluentialSelf-citationVaranita, T., Soriano, M. E., Romanello, V., Zaglia, T., Quintana-Cabrera, R., Semenzato, M., Menabò, R., Costa, V., Civiletto, G., Pesce, P., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.007 · Cited by 460 · see citing works
Self-citationMitochondrial quality control and muscle mass maintenance.
Romanello, V., & Sandri, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00422 · Cited by 434 · see citing works
Self-citationAutophagy Impairment in Muscle Induces Neuromuscular Junction Degeneration and Precocious Aging
Carnio, S., LoVerso, F., Baraibar, M. A., Longa, E., Khan, M. M., Maffei, M., Reischl, M., Canepari, M., Loefler, S., Kern, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.061 · Cited by 423 · see citing works
Self-citationThe starvation hormone, fibroblast growth factor-21, extends lifespan in mice
Zhang, Y., Xie, Y., Berglund, E. D., Coate, K. C., He, T. T., Katafuchi, T., Xiao, G., Potthoff, M. J., Wei, W., Wan, Y., et al. (2012) · eLife · doi:10.7554/elife.00065 · Cited by 420 · see citing works
DRP1-mediated mitochondrial shape controls calcium homeostasis and muscle mass
Favaro, G., Romanello, V., Varanita, T., Andrea Desbats, M., Morbidoni, V., Tezze, C., Albiero, M., Canato, M., Gherardi, G., De Stefani, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10226-9 · Cited by 398 · see citing works
Self-citationSebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593084 · Cited by 396 · see citing works
Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., et al. (2013) · Biogerontology · doi:10.1007/s10522-013-9432-9 · Cited by 340 · see citing works
Self-citationSingle Muscle Fiber Proteomics Reveals Fiber-Type-Specific Features of Human Muscle Aging
Murgia, M., Toniolo, L., Nagaraj, N., Ciciliot, S., Vindigni, V., Schiaffino, S., Reggiani, C., & Mann, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.054 · Cited by 315 · see citing works
Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates Mitochondrial Senescence
Song, M., Franco, A., Fleischer, J. A., Zhang, L., & Dorn, G. W. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.023 · Cited by 309 · see citing works
Brown, J. L., Rosa‐Caldwell, M. E., Lee, D. E., Blackwell, T. A., Brown, L. A., Perry, R. A., Haynie, W. S., Hardee, J. P., Carson, J. A., Wiggs, M. P., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12232 · Cited by 288 · see citing works
Ibebunjo, C., Chick, J. M., Kendall, T., Eash, J. K., Li, C., Zhang, Y., Vickers, C., Wu, Z., Clarke, B. A., Shi, J., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01036-12 · Cited by 267 · see citing works
Separate measures of ATP utilization and recovery in human skeletal muscle.
Blei, M. L., Conley, K. E., & Kushmerick, M. J. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019673 · Cited by 256 · see citing works
Effects of IGF-1 isoforms on muscle growth and sarcopenia
Ascenzi, F., Barberi, L., Dobrowolny, G., Villa Nova Bacurau, A., Nicoletti, C., Rizzuto, E., Rosenthal, N., Scicchitano, B. M., & Musarò, A. (2019) · Aging Cell · doi:10.1111/acel.12954 · Cited by 250 · see citing works
Blaauw, B., Canato, M., Agatea, L., Toniolo, L., Mammucari, C., Masiero, E., Abraham, R., Sandri, M., Schiaffino, S., & Reggiani, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-131870 · Cited by 244 · see citing works
Self-citationMechanisms of skeletal muscle aging: insights from <i>Drosophila</i> and mammalian models
Demontis, F., Piccirillo, R., Goldberg, A. L., & Perrimon, N. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012559 · Cited by 238 · see citing works
Fibroblast growth factor 21 controls mitophagy and muscle mass
Oost, L. J., Kustermann, M., Armani, A., Blaauw, B., & Romanello, V. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12409 · Cited by 231 · see citing works
Self-citationStress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy
Ebert, S. M., Dyle, M. C., Kunkel, S. D., Bullard, S. A., Bongers, K. S., Fox, D. K., Dierdorff, J. M., Foster, E. D., & Adams, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374777 · Cited by 221 · see citing works
Human Aging and Longevity Are Characterized by High Levels of Mitokines
Conte, M., Ostan, R., Fabbri, C., Santoro, A., Guidarelli, G., Vitale, G., Mari, D., Sevini, F., Capri, M., Sandri, M., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly153 · Cited by 219 · see citing works
Self-citationOpa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
Civiletto, G., Varanita, T., Cerutti, R., Gorletta, T., Barbaro, S., Marchet, S., Lamperti, C., Viscomi, C., Scorrano, L., & Zeviani, M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.016 · Cited by 216 · see citing works
Self-citationCancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Barreto, R., Mandili, G., Witzmann, F. A., Novelli, F., Zimmers, T. A., & Bonetto, A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00472 · Cited by 183 · see citing works
CaMKII?-cre transgene expression and recombination patterns in the mouse brain
Dragatsis, I., & Zeitlin, S. O. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2 · Cited by 171 · see citing works
Joseph, A.-M., Adhihetty, P. J., Wawrzyniak, N. R., Wohlgemuth, S. E., Picca, A., Kujoth, G. C., Prolla, T. A., & Leeuwenburgh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069327 · Cited by 161 · see citing works
Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation
Touvier, T., De Palma, C., Rigamonti, E., Scagliola, A., Incerti, E., Mazelin, L., Thomas, J.-L., D'Antonio, M., Politi, L., Schaeffer, L., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.595 · Cited by 140 · see citing works
Protein breakdown in cancer cachexia
Sandri, M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.002 · Cited by 134 · see citing works
Self-citationThe Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting
Ebert, S. M., Monteys, A. M., Fox, D. K., Bongers, K. S., Shields, B. E., Malmberg, S. E., Davidson, B. L., Suneja, M., & Adams, C. M. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0345 · Cited by 130 · see citing works
Zhou, J., Chong, S. Y., Lim, A., Singh, B. K., Sinha, R. A., Salmon, A. B., & Yen, P. M. (2017) · Aging · doi:10.18632/aging.101181 · Cited by 126 · see citing works
Age-dependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle
Pietrangelo, L., D’Incecco, A., Ainbinder, A., Michelucci, A., Kern, H., Dirksen, R. T., Boncompagni, S., & Protasi, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6139 · Cited by 101 · see citing works
Mitochondrial dynamics in cancer-induced cachexia
van der Ende, M., Grefte, S., Plas, R., Meijerink, J., Witkamp, R. F., Keijer, J., & van Norren, K. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.008 · Cited by 87 · see citing works
Trevisan, T., Pendin, D., Montagna, A., Bova, S., Ghelli, A. M., & Daga, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.017 · Cited by 86 · see citing works
Song, J., Lei, X., Jiao, W., Song, Y., Chen, W., Li, J., & Chen, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26918-z · Cited by 28 · see citing works
Bone and morphogenetic protein signalling and muscle mass
Sartori, R., & Sandri, M. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000172 · Cited by 22 · see citing works
Self-citationThe Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting
Ebert, S. M., Monteys, A. M., Fox, D. K., Bongers, K. S., Shields, B. E., Malmberg, S. E., Davidson, B. L., Suneja, M., & Adams, C. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.95.3.9993 · Cited by 3 · see citing works
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging
Leduc-Gaudet, J.-P., Hussain, S. N. A., Barreiro, E., & Gouspillou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158179 · Cited by 268 · see citing works
Signaling Pathways That Control Muscle Mass
Vainshtein, A., & Sandri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134759 · Cited by 213 · see citing works
Self-citationRomanello, V., & Sandri, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03662-0 · Cited by 197 · see citing works
Self-citationDysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer
Dai, W., & Jiang, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00570 · Cited by 188 · see citing works
Yang, X., Xue, P., Chen, H., Yuan, M., Kang, Y., Duscher, D., Machens, H., & Chen, Z. (2020) · Theranostics · doi:10.7150/thno.40857 · Cited by 147 · see citing works
Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective
Zhou, M., Yu, Y., Luo, X., Wang, J., Lan, X., Liu, P., Feng, Y., & Jian, W. (2021) · Cardiology · doi:10.1159/000518879 · Cited by 144 · see citing works
Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy
Mankhong, S., Kim, S., Moon, S., Kwak, H., Park, D., & Kang, J. (2020) · Cells · doi:10.3390/cells9061385 · Cited by 143 · see citing works
Zhou, H., & Toan, S. (2020) · Biomolecules · doi:10.3390/biom10010085 · Cited by 133 · see citing works
Hyatt, H. W., & Powers, S. K. (2021) · Antioxidants · doi:10.3390/antiox10040588 · Cited by 127 · see citing works
The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease
Zanfardino, P., Amati, A., Perrone, M., & Petruzzella, V. (2025) · Biomolecules · doi:10.3390/biom15030433 · Cited by 125 · see citing works
OPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle
Noone, J., O’Gorman, D. J., & Kenny, H. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.003 · Cited by 119 · see citing works
Impact of Melatonin on Skeletal Muscle and Exercise
Stacchiotti, A., Favero, G., & Rodella, L. F. (2020) · Cells · doi:10.3390/cells9020288 · Cited by 115 · see citing works
Lei, Y., Gan, M., Qiu, Y., Chen, Q., Wang, X., Liao, T., Zhao, M., Chen, L., Zhang, S., Zhao, Y., et al. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00572-y · Cited by 100 · see citing works
The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia
Romanello, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010091 · Cited by 101 · see citing works
Self-citationAvellaneda, J., Rodier, C., Daian, F., Brouilly, N., Rival, T., Luis, N. M., & Schnorrer, F. (2021) · Nature Communications · doi:10.1038/s41467-021-22058-7 · Cited by 92 · see citing works
Kondadi, A. K., Anand, R., & Reichert, A. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174311 · Cited by 90 · see citing works
Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
Li, R., Toan, S., & Zhou, H. (2020) · Aging · doi:10.18632/aging.102972 · Cited by 90 · see citing works
Energy metabolism design of the striated muscle cell
Glancy, B. C., & Balaban, R. S. (2021) · Physiological Reviews · doi:10.1152/physrev.00040.2020 · Cited by 83 · see citing works
Goljanek‐Whysall, K., Soriano‐Arroquia, A., McCormick, R., Chinda, C., & McDonagh, B. (2020) · Aging Cell · doi:10.1111/acel.13140 · Cited by 81 · see citing works
“Interestingly, inducible muscle-specific deletion of both OPA1 and DRP1 rescued the lethal phenotype of OPA1 knockout, suggesting that in the context of mitochondrial dynamics inhibition of fission has precedence over inhibition of fusion (Romanello et al., 2019).”
BackgroundMitochondrial uncoupling and longevity – A role for mitokines?
Klaus, S., & Ost, M. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110796 · Cited by 79 · see citing works
Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging
Anagnostou, M., & Hepple, R. T. (2020) · Cells · doi:10.3390/cells9010197 · Cited by 81 · see citing works
Mitochondrial Quality Control in Sarcopenia: Updated Overview of Mechanisms and Interventions
Liu, D., Fan, Y., Tao, X., Pan, W., Wu, Y., Wang, X., He, Y., Xiao, W., & Li, Y. (2021) · Aging and Disease · doi:10.14336/ad.2021.0427 · Cited by 60 · see citing works
Ageing of skeletal muscle extracellular matrix and mitochondria: finding a potential link
Cai, L., Shi, L., Peng, Z., Sun, Y., & Chen, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2240707 · Cited by 60 · see citing works
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging
Fealy, C. E., Grevendonk, L., Joris Hoeks, J., & Hesselink, M. K. C. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.013 · Cited by 58 · see citing works
Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy
Gallot, Y. S., & Bohnert, K. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052567 · Cited by 59 · see citing works
Autophagy in sarcopenia: Possible mechanisms and novel therapies
Xie, G., Jin, H., Mikhail, H., Pavel, V., Yang, G., Ji, B., Lu, B., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115147 · Cited by 57 · see citing works
Myokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58 · see citing works
Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 54 · see citing works
From mitochondria to sarcopenia: role of 17β-estradiol and testosterone
Tian, X., Lou, S., & Shi, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156583 · Cited by 54 · see citing works
The emerging role of skeletal muscle mitochondrial dynamics in exercise and ageing
Casuso, R. A., & Huertas, J. R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101025 · Cited by 54 · see citing works
Sarcopenia in head and neck cancer: A scoping review
Jovanovic, N., Chinnery, T., Mattonen, S. A., Palma, D. A., Doyle, P. C., & Theurer, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278135 · Cited by 51 · see citing works
Standpoints in mitochondrial dysfunction: Underlying mechanisms in search of therapeutic strategies
Videla, L. A., Mariman, A. P., Ramos, B., Silva, M. J., & del Campo, A. (2022) · Mitochondrion · doi:10.1016/j.mito.2021.12.006 · Cited by 48 · see citing works
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease
Boardman, N. T., Trani, G., Scalabrin, M., Romanello, V., & Wüst, R. C. I. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad004 · Cited by 49 · see citing works
Self-citationIs mitochondrial morphology important for cellular physiology?
Wai, T. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.05.005 · Cited by 48 · see citing works
Implications of mitochondrial fusion and fission in skeletal muscle mass and health
Romanello, V., & Sandri, M. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.02.011 · Cited by 44 · see citing works
Self-citationThe Role of Mitochondria in Mediation of Skeletal Muscle Repair
Alway, S. E., Paez, H. G., & Pitzer, C. R. (2023) · Muscles · doi:10.3390/muscles2020011 · Cited by 42 · see citing works
Regulatory Roles of PINK1-Parkin and AMPK in Ubiquitin-Dependent Skeletal Muscle Mitophagy
Seabright, A. P., & Lai, Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.608474 · Cited by 41 · see citing works
Regulatory networks coordinating mitochondrial quality control in skeletal muscle
Slavin, M. B., Memme, J. M., Oliveira, A. N., Moradi, N., & Hood, D. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00065.2022 · Cited by 40 · see citing works
From mitochondria to sarcopenia: Role of inflammaging and RAGE-ligand axis implication
Daussin, F., Boulanger, É., & Lancel, S. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111247 · Cited by 41 · see citing works
Zaninello, M., Palikaras, K., Sotiriou, A., Tavernarakis, N., & Scorrano, L. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00847-3 · Cited by 40 · see citing works
Self-citationZhang, Z., Cui, D., Zhang, T., Sun, Y., & Ding, S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s243024 · Cited by 39 · see citing works
Oikawa, Y., Izumi, R., Koide, M., Hagiwara, Y., Kanzaki, M., Suzuki, N., Kikuchi, K., Matsuhashi, T., Akiyama, Y., Ichijo, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231064 · Cited by 36 · see citing works
Khin, P. P., Hong, Y., Yeon, M., Lee, D. H., Lee, J. H., & Jun, H. (2021) · Aging · doi:10.18632/aging.203546 · Cited by 37 · see citing works
The integrated stress response as a key pathway downstream of mitochondrial dysfunction
Bilen, M., Benhammouda, S., Slack, R. S., & Germain, M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100555 · Cited by 31 · see citing works
Mao, X., Gu, Y., Sui, X., Shen, L., Han, J. S., Wang, H., Xi, Q., Zhuang, Q., Meng, Q., & Wu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673618 · Cited by 30 · see citing works
Cabrera, A. R., Deaver, J. W., Lim, S., da Silva, F. M., Schrems, E. R., Saling, L. W., Tsitkanou, S., Rosa‐Caldwell, M. E., Wiggs, M. P., Washington, T. A., et al. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00196.2023 · Cited by 29 · see citing works
Master World Records show minor gender differences of performance decline with aging
Gava, P., & Ravara, B. (2019) · European Journal of Translational Myology · doi:10.4081/ejtm.2019.8327 · Cited by 26 · see citing works
The redox environment and mitochondrial dysfunction in age-related skeletal muscle atrophy
Shally, A., & McDonagh, B. (2020) · Biogerontology · doi:10.1007/s10522-020-09879-7 · Cited by 24 · see citing works
Noone, J., Rochfort, K. D., O’Sullivan, F., & O’Gorman, D. J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110931 · Cited by 19 · see citing works
Xu, X., & Wen, Z. (2023) · PubMed Central · Cited by 19 · see citing works
Arroum, T., Hish, G. A., Burghardt, K. J., Ghamloush, M., Bazzi, B., Mrech, A., Morse, P. T., Britton, S. L., Koch, L. G., McCully, J. D., et al. (2024) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000004793 · Cited by 18 · see citing works
Regulation of diurnal energy balance by mitokines
Klaus, S., Gil, C. I., & Ost, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03748-9 · Cited by 17 · see citing works
Cancer-associated muscle weakness - From triggers to molecular mechanisms
Shorter, E., Engman, V., & Lanner, J. T. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101260 · Cited by 16 · see citing works
MicroRNAs as the Sentinels of Redox and Hypertrophic Signalling
Kolodziej, F., McDonagh, B., Burns, N. C., & Goljanek‐Whysall, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314716 · Cited by 15 · see citing works
Zanfardino, P., Amati, A., Doccini, S., Cox, S. N., Tullo, A., Longo, G., D’Erchia, A. M., Picardi, E., Nesti, C., Santorelli, F. M., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae008 · Cited by 13 · see citing works
Alterations in peroxisome-mitochondria interplay in skeletal muscle accelerate muscle dysfunction
Scalabrin, M., Turco, E., Davigo, I., Filadi, R., Nogara, L., Gherardi, G., Barazzuol, L., Armani, A., Trani, G., Negro, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64833-w · Cited by 13 · see citing works
Self-citationMitochondrial dynamics: roles in exercise physiology and muscle mass regulation
Djalalvandi, A., & Scorrano, L. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100550 · Cited by 12 · see citing works
Self-citationLeveraging mitochondrial stress to improve healthy aging
Gorgori-González, A., Soto-Rodriguez, S., Tamayo-Torres, E., García-Domínguez, E., Sebastiá, V., Gambini, J., González, G. O., & Gómez‐Cabrera, M. C. (2025) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2025.10.003 · Cited by 12 · see citing works
Yeh, K., Ling, H. H., Ng, S., Wang, C., Chang, P., Chou, W., Chen, F., & Lin, Y. (2021) · Diagnostics · doi:10.3390/diagnostics11020309 · Cited by 10 · see citing works
Zhang, X., Liao, S., Huang, L., & Wang, J. (2024) · Advanced Biology · doi:10.1002/adbi.202400235 · Cited by 10 · see citing works
Zhang, C., Zheng, X., Xiang, L., & Su, Z. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05441-6 · Cited by 9 · see citing works
Mahmoud, S. A., Abdel-Aziz, M. M., Khafaga, R. H. M., Hafez, H. A., Kamel, M. A. E.-N., & Shaker, S. A. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00666-x · Cited by 9 · see citing works
Streeter, J., Persaud, L., Gao, J., Manika, D., Fairman, W., García-Peña, L. M., Marti, A., Manika, C., Gaddi, S., Schickling, B., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1325286 · Cited by 8 · see citing works
Marshall, R. N., McKendry, J., Smeuninx, B., Seabright, A. P., Morgan, P. T., Greig, C. A., & Breen, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1097988 · Cited by 8 · see citing works
Lin, Y., Wang, C., Ling, H. H., Pan, Y., Chang, P., Chou, W., Chen, F., & Yeh, K. (2022) · Biomedicines · doi:10.3390/biomedicines10020388 · Cited by 7 · see citing works
Kitaoka, Y., Watanabe, D., Nonaka, Y., Yagishita, K., Kano, Y., & Hoshino, D. (2019) · Physiological Reports · doi:10.14814/phy2.14266 · Cited by 6 · see citing works
The NLRP3 Mediates Masticatory Muscle Atrophy by Pyroptosis and Mitophagy
Li, Q., Gao, A., Wu, C., Song, X., Liu, W., Cheng, Y., Li, T., Zhang, K., Chen, Y., Liu, X., et al. (2025) · Journal of Dental Research · doi:10.1177/00220345251344295 · Cited by 3 · see citing works
Role of mitochondrial dysfunction in muscle wasting in cancer cachexia: a narrative review
Su, X., Wang, S., Qu, Y., Wang, Y., Tian, Z., Chao, X., Li, Z., & Ma, D. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07906-8 · Cited by 3 · see citing works
Mechanistic of AMPK/ACC2 regulating myoblast differentiation by fatty acid oxidation of goat
Kang, Z., Zhang, Z., Li, J., Deng, K., Wang, F., & Fan, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132243 · Cited by 3 · see citing works
Mao, X., Meng, Q., Han, J., Shen, L., Sui, X., Gu, Y., & Wu, G. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-751 · Cited by 3 · see citing works
Ma, M., Li, J., Pang, W., Zhang, Z., Zhang, Y., & Hai, B. (2026) · Cells · doi:10.3390/cells15121091 · Cited by 2 · see citing works
Ravara, B., Gava, P., Taylor, M. J., & Pond, A. L. (2019) · Physiotherapy Research and Reports · doi:10.15761/prr.1000125 · Cited by 2 · see citing works
Mitochondrial Function in Aging
Morales-Rosales, S. L., Rivero-Segura, N. A., & Königsberg, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_4 · Cited by 3 · see citing works
Lin, Y., Ling, H. H., Chang, P., Pan, Y., Wang, C., Chou, W., Chen, F., & Yeh, K. (2021) · Diagnostics · doi:10.3390/diagnostics11071203 · Cited by 2 · see citing works
Key Signalling Molecules in Aging and Neurodegeneration
Filadi, R., & Pizzo, P. (2022) · Cells · doi:10.3390/cells11050834 · Cited by 2 · see citing works
Redox signalling and microRNA feedback in exercise-mediated skeletal muscle remodelling
Qin, X., Goljanek‐Whysall, K., & McDonagh, B. (2025) · Advances in Redox Research · doi:10.1016/j.arres.2025.100133 · Cited by 1 · see citing works
Linking mitochondrial dysfunction to sarcopenia
Alway, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00004-1 · Cited by 1 · see citing works
The Role of Mitochondria in Age‐Related Sarcopenia
Ferrucci, L., Zampino, M., Coen, P. M., & Goodpaster, B. H. (2021) · Wiley eBooks · doi:10.1002/9781119597896.ch3 · Cited by 1 · see citing works
Lessons from Masters World Records: Lack of Gender Differences In Aging Muscle Decay Rates
Albertin, G. (2020) · Research & Investigations in Sports Medicine · doi:10.31031/rism.2020.06.000626
Skeletal muscle health in aging
Grevendonk, L. (2021) · doi:10.26481/dis.20211006lg
Duan, D., Qin, J., Wang, X., Fan, Y., Ji, L., & Feng, M. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152235
RetractedMelatonin ve Çinkonun Egzersize Katkıları
Kaya, O. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2575
Tu, J., Zhang, S., Hong, W., Wang, Y., Han, Y., Xue, C., & Dong, N. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.005
Endoplasmic reticulum autophagy in inflammatory diseases
Wang, C., Gao, J., Guo, C., Li, Q., Wang, F., & Zhang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1822159
The nervous system as a systemic organizer of cancer-associated cachexia
Weng, Z., Cai, S., Zhu, H., Jiang, L., Zhang, S., Zhang, Z.-G., & Jiang, S. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.08.002
- Authors
- Romanello, V., Scalabrin, M., Albiero, M., Blaauw, B., Scorrano, L., & Sandri, M.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Romanello, Vanina
- Sandri, Marco
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-06-15
- Volume
- 8
- Issue
- 6
- Pages
- 597
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6627087
- OpenAlex
- W2950038861
- Semantic Scholar
- d3210603099e4815011a830458a8cd900eba6c38
- Cited by
- 91
- References
- 43
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 21 · 2020: 19 · 2019: 6
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- European Research Council (282310-MyoPHAGY)
- AFM-Téléthon (19524)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2010/2011)
- Fondation Leducq (Leducq)
- Associazione Italiana per la Ricerca sul Cancro (17388)
- H2020 Marie Skłodowska-Curie Actions (RISE-2014 645648)
- Fondazione Cassa di Risparmio di Padova e Rovigo (STARTING GRANT)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- OPA1, Drp1, mitochondrial fission, mitochondrial fusion, skeletal muscle atrophy, FGF21, muscle-specific knockout mice, mitophagy, autophagy, endoplasmic reticulum stress, oxidative stress, denervation, muscle inflammation, mitochondrial dysfunction
- MeSH terms
- Aging, Animals, Autophagy, Fibroblast Growth Factors, Mitochondria, Muscular Atrophy, Mice, Knockout, Oxidative Stress, Muscle, Skeletal, Muscle Weakness, GTP Phosphohydrolases, Ubiquitin, Dynamins, Proteasome Endopeptidase Complex, Proteolysis, Endoplasmic Reticulum Stress, Mitochondrial Dynamics, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review